DISSECT AND TARGET THE AR-SKP2 PATHWAY TO INHIBIT PROLIFERATION, BUT NOT DIFFERENTIATION, OR ANDROGEN-DEPENDENT PROSTATE CANCER CELLS
$0FY2009Department of the ArmyDOD
Yeshiva University, New York NY
Investigators
View source on USAspending →DISSECT AND TARGET THE AR-SKP2 PATHWAY TO INHIBIT PROLIFERATION, BUT NOT DIFFERENTIATION, OR ANDROGEN-DEPENDENT PROSTATE CANCER CELLS · GrantIndex